Evidence map›Paper›PMID 41178050›Full record

ArticlePhysiological reports2025

Metabolic changes in dorsal root ganglia of newborn Wistar rats following LPS exposure to understand mechanisms of critical illness polyneuropathy.

Amandine Szczesnowski, Christelle Le Gall-Ianotto, Marie-Dominique Jezequel, Michaël Théron, Karelle Léon, Karine Pichavant-Rafini

Abstract read
In one paragraph

Article in Physiological reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amandine SzczesnowskiORPHY, Univ Brest, Brest, France.ORCID 0009-0009-3025-7038
Christelle Le Gall-IanottoDepartment of Dermatology, University Hospital, Brest, France.
Marie-Dominique JezequelORPHY, Univ Brest, Brest, France.
Michaël ThéronORPHY, Univ Brest, Brest, France.
Karelle LéonORPHY, Univ Brest, Brest, France.
Karine Pichavant-RafiniORPHY, Univ Brest, Brest, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a public health issue, associated with complications as critical illness polyneuropathy (CIP). This study investigates how mitochondrial dysfunction could contribute to CIP by examining metabolic changes in dorsal root ganglia (DRG) culture from newborn Wistar rats exposed to different concentrations of lipopolysaccharide (5, 10, 50, and 100 μg/mL for 24 or 48 h). Cell viability was assessed using the MTS assay, gene expression related to inflammation and mitochondrial function was analyzed by Real-Time PCR. IL-6 levels of supernatants were measured by ELISA and energetic metabolism was evaluated with the Seahorse MitoStress kit. Exposure to LPS at varying concentrations mainly did not affect cell viability, except at 10 μg/mL for 48 h, where a 7.5% increase was noted. Gene expression analysis showed trends in SOD2 and Fis1, with significant increases in IL-6 and LIF transcripts at 5 and 10 μg/mL. IL-6 release was significant at 50 and 100 μg/mL of LPS. Mitochondrial respiration and glycolytic metabolism exhibited significant changes in oxygen consumption rate and extracellular acidification, particularly at higher LPS concentrations. The findings suggest that LPS induces an inflammatory environment which led to metabolic disturbances in DRG cells, with adaptive responses at 10 and 50 μg/mL of LPS.

Indexed as

Ganglia, SpinalLipopolysaccharidesPolyneuropathiesAnimalsAnimals, NewbornCells, CulturedCell SurvivalEnergy MetabolismInterleukin-6MitochondriaRatsRats, WistarInterleukin-6Lipopolysaccharidesdorsal root gangliaglycolysislipopolysaccharideoxidative phosphorylation

Identifiers

PMID41178050
PMCPMC12580404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.